Shehnaaz Suliman

(Shehnaaz Suliman)

Currently holds positions in Ultragenyx Pharmaceutical Inc and Alector Inc

Positions

Position Company Period
Independent Director Ultragenyx Pharmaceutical Inc Jan. 30, 2019 -
President, Chief Operating Officer Alector Inc Dec. 11, 2019 -
Senior Vice President - Corporate Development and Strategy Theravance Biopharma Inc July 31, 2017 - Dec. 31, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-14 2021-12-13
US Alector Inc (ALEC)
PS Planned sale
10,898 -9.6%
21.73
USD 236,802 		10,898 -9.6% 21.73 USD 236,802
2021-12-14 2021-12-13
US Alector Inc (ALEC)
PS Planned sale
64,102 -36.1%
21.16
USD 1,356,347 		64,102 -36.1% 21.16 USD 1,356,347
2021-12-14 2021-12-10
US Alector Inc (ALEC)
PS Planned sale
8,874 -8.0%
22.33
USD 198,192 		8,874 -8.0% 22.33 USD 198,192
2021-12-14 2021-12-10
US Alector Inc (ALEC)
PS Planned sale
66,126 -37.2%
21.69
USD 1,433,975 		66,126 -37.2% 21.69 USD 1,433,975
2021-12-10 2021-12-09
US Alector Inc (ALEC)
PS Planned sale
2,643 -2.5%
23.40
USD 61,858 		2,643 -2.5% 23.40 USD 61,858
2021-12-10 2021-12-09
US Alector Inc (ALEC)
PS Planned sale
72,357 -40.7%
22.80
USD 1,649,986 		72,357 -40.7% 22.80 USD 1,649,986
2021-12-10 2021-12-08
US Alector Inc (ALEC)
PS Planned sale
38,489 -27.3%
23.01
USD 885,690 		38,489 -27.3% 23.01 USD 885,690
2021-12-10 2021-12-08
US Alector Inc (ALEC)
PS Planned sale
36,511 -20.6%
22.56
USD 823,626 		36,511 -20.6% 22.56 USD 823,626
// ... existing code ... // ... rest of the file ...